Liver Diseases  >>  IC 41  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IC 41 / Valneva, Novartis
NCT00602784: Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine

Completed
2
66
Europe
IC41
Valneva Austria GmbH
Chronic Hepatitis C
05/04
09/04
NCT00601770 / 2006-002034-37: Virological Response Study of the HCV Vaccine IC41

Completed
2
71
Europe
IC41
Valneva Austria GmbH
Chronic Hepatitis C
07/08
07/08

Download Options